Abstract
BackgroundTacrolimus (TAC) is used as a disease modifying antirheumatic drug (DMARD) in rheumatoid arthritis (RA). Combination of TAC with methotrexate (MTX) has been shown to be effective and safe in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
